December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear dose-response observed, with a robust and clinically meaningful…
CHICAGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Misophonia Research Fund (MRF), an initiative of the REAM Foundation, announces a…
BHUBANESWAR, India, Oct. 13, 2025 /PRNewswire/ -- KIIT Deemed to be University, (https://kiit.ac.in/), Bhubaneswar has made a big impact in the…
ABU DHABI,UAE, Aug. 16, 2025 /PRNewswire/ -- Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has welcomed its largest cohort…
AHMEDABAD, India, July 30, 2025 /PRNewswire/ -- CEPT University marked the beginning of the Monsoon Semester 2025 with the arrival…
NULISAseq™ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker Discovery in 23,000 Longitudinal Samples FREMONT, Calif., July…
July 25, 2025 16:05 ET | Source: Celcuity Inc. MINNEAPOLIS, July 25, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC),…
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused…
11 of 12 participants (92%) enrolled in the 180mg cohort achieved a complete response 12 of 12 participants (100%) in…
From Mumbai to the world—experience education through a dual-campus global management programme MUMBAI, India, June 5, 2025 /PRNewswire/ -- Bharatiya Vidya Bhavan's…